The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 1, 1999, Pages 11-18

  Mort, J S ^a   Buttle, D J ^b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Aggregan; Cleavage site specific antibodies; Collagen; Protein synthesis; Proteolysis

Indexed keywords

COLLAGEN TYPE 2; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; PEPTIDE; POLYCLONAL ANTIBODY; PROTEIN;

ADULT; AGED; ARTHRITIS; ARTICULAR CARTILAGE; CHEMICAL BOND; FEMALE; HUMAN; HUMAN TISSUE; HYDROLYSIS; MALE; PATHOGENESIS; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVIEW;

EID: 0032931557     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.1.11     Document Type: Review

References (43)

1. 1 Kühn K. The classical collagens: types I, II, and III. In: R Maybe, RE Burgeson, eds. Structure and function of collagen types. San Diego: Academic Press, 1987:1-42.
2. 2 Baumeister W, Cejka Z, Kania M, et al. The proteasome: a macromolecular assembly designed to confine proteolysis to a nanocompartment. Biol Chem 1997;378:121-30.
3. 3 Haass C, Selkoe DJ. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 1993;75:1039-42.
4. 4 Steer ML. How and where does acute pancreatitis begin? Arch Surg 1992;127:1350-3.
5. 5 Couser WG. Pathogenesis of glomerulonephritis. Kidney Int Suppl 1993;42:S19-26.
6. 6 Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993;71:1368-83.
7. 7 Poole AR. Cartilage in health and disease. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology. Baltimore: Williams and Wilkins, 1997:255-308.
8. 8 Zaidi M, Alam ASMT, Shankar VS, et al. Cellular biology of bone resorption. Biol Rev 1993;68:197-264.
9. 9 Knight KR, Burdon JG, Cook L, et al. The proteinase antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema. Respirology 1997;2:91-5.
10. 10 Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997;59:63-88.
11. 11 Caterson B, Hughes CE, Johnstone B, Mort JS. Immunological markers of cartilage proteoglycan metabolism in animal and human osteoarthritis. In: Kuettner KE, Schleyerbach R, Peyron JG, et al., eds. Articular cartilage and osteoarthritis. New York: Raven Press, 1992:415-27.
12. 12 Weber C, Katayama J, Springer TA. Differential regulation of β1 and β2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci USA 1996;93:10939-44.
13. 13 Hollander AP, Heathfield TF, Webber C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93: 1722-32.
14. 14 Strickland DK, Steiner JP, Miglioini M, et al. Identification of a monoclonal antibody specific for a neoantigenic determinant on alpha-2-macroglobulin: use for the purification and characterization of binary proteinase-inhibitor complexes. Biochemistry 1988;27:1458-66.
15. 15 Young AC, Valadon P, Casadevall A, et al. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J Mol Biol 1997;274: 622-34.
16. 16 Wilson IA, Stanfield RL. Antibody antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol 1994;4:857-67.
17. 17 Liang H, Fesik SW. Three-dimensional structures of proteins involved in programmed cell death. J Mol Biol 1997;274:291-302.
18. 18 Pacella BJ, Hui KY, Haber E, et al. Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites. Mol Immunol 1983;20:521-7.
19. 19 Hui KY, Haber E, Matsuoda GR. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 1983;222:1129-32.
20. 20 Saido TC, Nagao S, Shiramine M, et al. Autolytic transition of mu-calpain upon activation as resolved by antibodies distinguishing between the pre- and post-autolysis forms. J Biochem 1992;111:81-6.
21. 21 Kikuchi H, Imajoh-Ohmi S, Kanegasaki S. Novel antibodies specific for proteolyzed forms of protein kinase C: production of anti-peptide antibodies available for in situ analysis of intracellular limited proteolysis. Biochim Biophys Acta 1993;1162:171-6.
22. 22 Poole AR, Mort JS, Roughley PJ. Methods for evaluating mechanisms of cartilage breakdown. In: Woessner JF, Howell DS, eds. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker, 1993:225-60.
23. 23 Hughes CE, Caterson B, White RJ, et al. Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation: application to studies of human link protein cleaved by stromelysin. J Biol Chem 1992;267:16011-14.
24. 24 Nguyen Q, Liu J, Roughley PJ, et al. Link protein as a monitor in situ of endogenous proteolysis in human articular cartilage. Biochem J 1991;278:143-7.
25. 25 Nguyen Q, Murphy G, Hughes CE, et al. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem J 1993;295:595-8.
26. 26 Hughes CE, Caterson B, Fosang AJ, et al. Monoclonal antibodies that specifically recognize neoepitope sequences generated by "aggrecanase" and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 1995;305:799-804.
27. 27 Lark MW, Williams H, Hoernner LA, et al. Quantitation of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum. Biochem J 1995;307:245-52.
28. 28 Fosang AJ, Last K, Gardiner P, et al. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluid. Biochem J 1995;310:337-43.
29. 29 Lark MW, Bayne EK, Flanagan J, et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100:93-106.
30. 30 Sztrolovics R, Alini M, Roughley PJ, et al. Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J 1997;326:235-41.
31. 31 Singer H, Scott S, Kawka DW, et al. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis. Osteoarthritis Cartilage 1998;5:407-18.
32. 342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate. Anat Rec 1998;252:117-32.
33. 33 Shingleton WD, Hodges DJ, Brick P, et al. Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol 1996;74:759-75.
34. 34 Martel-Pelletier J, Pelletier JP. Wanted the collagenase responsible for the destruction of the collagen network in human cartilage! Br J Rheumatol 1996;35:818-20.
35. 35 Billinghurst RC, Dahlberg L., Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
36. 36 Vankemmelbeke M, Dekeyser PM, Hollander AP, et al. Characterization of helical cleavages in type II collagen generated by matrixins. Biochem J 1998;330:633-40.
37. 37 Bernatowicz MS, Matsueda GR. Preparation of peptide protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent. Anal Biochem 1986;155:95-102.
38. 38 Roughley PJ, White RJ, Mort JS. The presence of pro-forms of decorin and biglycan in human articular cartilage. Biochem J 1996;318:779-84.
39. 39 Fosang AJ, Last K, Maciewicz RA. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinases and aggrecanase activities can be independent. J Clin Invest 1996;98:2292-9.
40. 40 Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987;262:10035-8.
41. 41 Buttle DJ, Fowles A, Ilic MZ, et al. "Aggrecanase" activity is implicated in tumour necrosis factor α mediated cartilage aggrecan breakdown but is not detected by an in vitro assay. J Clin Pathol: Mol Pathol 1997;50:153-9.
42. 42 Sandy JD, Neame PJ, Boynton RE, et al. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 1991;266:8683-5.
43. 43 Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid: evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury and osteoarthritis. Arthritis Rheum 1993;36:1214-22.